Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study
- PMID: 16540545
- PMCID: PMC1798288
- DOI: 10.1136/ard.2005.051169
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study
Conflict of interest statement
Competing interests: None declared.
References
-
- Criscione L G, St Clair E W. Tumor necrosis factor‐alpha antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol 200214204–211. - PubMed
-
- Edwards J C, Szczepanski L, Szechinski J, Filipowicz‐Sosnowska A, Emery P, Close D R.et al Efficacy of B‐cell‐targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 20043502572–2581. - PubMed
-
- Arnett F C, Edworthy S M, Bloch D A, McShane D J, Fries J F, Cooper N S.et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 198831315–324. - PubMed
-
- van Gestel A M, Haagsma C J, van Riel P L. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998411845–1850. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
